Review of the safety, efficacy, costs and patient acceptability of recombinant follicle-stimulating hormone for injection in assisting ovulation induction in infertile women

Anovulation is a common cause of female subfertility. Treatment of anovulation is aimed at induction of ovulation. In women with clomiphene-citrate resistant WHO group II anovulation, one of the treatment options is ovulation induction with exogenous follicle-stimulating hormone (FSH or follitropin)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahuis, Marleen, van der Veen, Fulco, Oosterhuis, Jur, Mol, Ben Willem, Hompes, Peter, van Wely, Madelon
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971716/
https://www.ncbi.nlm.nih.gov/pubmed/21072289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2971716/
https://www.ncbi.nlm.nih.gov/pubmed/21072289

Ejemplares similares